Rebound Pain Impact After Hip Surgery With Nerve Block
Conditions
Brief summary
Postoperative delirium is a significant and commonly encountered complication in patients undergoing hip surgery, particularly among the elderly. Postoperative delirium is associated with serious consequences, including prolonged intensive care unit stay, increased complication rates, higher mortality risk, and rising healthcare costs. The incidence of Postoperative delirium after hip fracture surgery has been reported to range between 13% and 55.9%, indicating a substantial clinical burden. Effective postoperative pain control is critical not only for maintaining quality of life but also for preserving cognitive well-being. In this context, peripheral nerve blocks are frequently used for pain management following hip surgery.
Detailed description
Postoperative delirium is a significant and commonly encountered complication in patients undergoing hip surgery, particularly among the elderly. Postoperative delirium is associated with serious consequences, including prolonged intensive care unit stay, increased complication rates, higher mortality risk, and rising healthcare costs. The incidence of Postoperative delirium after hip fracture surgery has been reported to range between 13% and 55.9%, indicating a substantial clinical burden. Effective postoperative pain control is critical not only for maintaining quality of life but also for preserving cognitive well-being. In this context, peripheral nerve blocks are frequently used for pain management following hip surgery. In recent years, the Pericapsular Nerve Group block and the supra-inguinal fascia iliaca block have gained attention as regional anesthesia techniques that provide effective analgesia by targeting the nerve branches innervating the anterior capsule of the hip joint.
Interventions
OTHERPeripheral nerve block applied
Pericapsular Nerve Group block and the supra-inguinal fascia iliaca block applied
OTHEROnly multimodal analgesia applied
Postoperative analgesia (paracetamol 1000 mg intravenously every 8 hours and celecoxib 200 mg orally every 12 hours)
Sponsors
Konya City Hospital
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Patients aged 18-80 * ASA I-III risk groups * Undergoing elective hip surgery
Exclusion criteria
* Preoperative history of delirium, dementia, or major neurological disease * Present cognitive impairment or severe hearing or visual impairment that could affect pain assessment * Development of mechanical ventilation requirement in the intensive care unit; Need for bilateral hip surgery * Failure to provide meaningful analgesia after block application due to surgical pain outside the scope of the block * Patient's inability to complete the pain diary during postoperative follow-up; * Urgent hip surgery * Voluntary failure to give consent or request to withdraw from the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of delirium | 72 hours | The incidence of delirium will be evaluated in the first 72 hours postoperatively in the intensive care unit. |
Countries
Turkey (Türkiye)
Contacts
CONTACTHasan SENAY, M.D.
Outcome results
None listed